Unity Biotechnology

Unity Biotechnology company information, Employees & Contact Information

UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases. As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology.

Company Details

Employees
28
Founded
-
Address
285 E Grand Ave, South San Francisco,california 94080,united States
Phone
617-563-5800
Email
in****@****ogy.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
South San Francisco, California
Looking for a particular Unity Biotechnology employee's phone or email?

Unity Biotechnology Questions

News

UNITY Biotechnology Announces Complete 36-Week Results from - GlobeNewswire

UNITY Biotechnology Announces Complete 36-Week Results from GlobeNewswire

UBX1325 fails to meet primary analysis endpoint despite vision gains in DME - Healio

UBX1325 fails to meet primary analysis endpoint despite vision gains in DME Healio

Unity Biotechnology announces upcoming trial data and new board of directors member - Ophthalmology Times

Unity Biotechnology announces upcoming trial data and new board of directors member Ophthalmology Times

UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 - Yahoo Finance

UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 Yahoo Finance

UNITY Biotechnology Appoints Federico Grossi, M.D., Ph.D., as Chief Medical Officer to Enhance Clinical Development Efforts - Quiver Quantitative

UNITY Biotechnology Appoints Federico Grossi, M.D., Ph.D., as Chief Medical Officer to Enhance Clinical Development Efforts Quiver Quantitative

UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewswire

UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates GlobeNewswire

Unity Biotechnology stock plunges after Nasdaq delisting notice - Investing.com

Unity Biotechnology stock plunges after Nasdaq delisting notice Investing.com

Unity Biotechnology has eliminated the entire workforce as strategic options dwindle - HR Katha

Unity Biotechnology has eliminated the entire workforce as strategic options dwindle HR Katha

UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema - GlobeNewswire

UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema GlobeNewswire

We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate - Yahoo Finance

We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate Yahoo Finance

10 start-ups on a mission to extend lives - Swiss Life-Gruppe

10 start-ups on a mission to extend lives Swiss Life-Gruppe

Removing Senescent Cells May Slow, Halt, or Reverse Diseases of Aging - Genetic Engineering and Biotechnology News

Removing Senescent Cells May Slow, Halt, or Reverse Diseases of Aging Genetic Engineering and Biotechnology News

Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema - Ophthalmology Times

Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema Ophthalmology Times

UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 - Yahoo Finance

UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 Yahoo Finance

UNITY Biotechnology Announces Positive 24-Week Data from - GlobeNewswire

UNITY Biotechnology Announces Positive 24-Week Data from GlobeNewswire

UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration - Yahoo Finance

UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration Yahoo Finance

UNITY Biotechnology Announces 12-week data from UBX0101 - GlobeNewswire

UNITY Biotechnology Announces 12-week data from UBX0101 GlobeNewswire

UNITY Biotechnology to Participate in Upcoming March Investor Conferences - Yahoo Finance

UNITY Biotechnology to Participate in Upcoming March Investor Conferences Yahoo Finance

UNITY Biotechnology Announces Positive Data in Phase 2 - GlobeNewswire

UNITY Biotechnology Announces Positive Data in Phase 2 GlobeNewswire

UNITY Biotechnology Announces Reverse Stock Split Effective at 5:00 PM Eastern Time Today - Yahoo Finance

UNITY Biotechnology Announces Reverse Stock Split Effective at 5:00 PM Eastern Time Today Yahoo Finance

Why Jeff Bezos is backing this Silicon Valley scientist who is working on a cure for aging - CNBC

Why Jeff Bezos is backing this Silicon Valley scientist who is working on a cure for aging CNBC

Jeff Bezos, Mayo Clinic back anti-aging startup Unity Biotechnology for $116 million - TechCrunch

Jeff Bezos, Mayo Clinic back anti-aging startup Unity Biotechnology for $116 million TechCrunch

Top Unity Biotechnology Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant